Christopher M. Burns, Robert L. Wortmann: Latest evidence on gout management: what the clinician needs to know. In: Therapeutic Advances in Chronic Disease. Band3, Nr.6, November 2012, S.271–286, doi:10.1177/2040622312462056, PMID 23342241, PMC 3539261 (freier Volltext).
Erica M. Hill, Karen Sky, Michelle Sit, Angelique Collamer, Jay Higgs: Does starting allopurinol prolong acute treated gout? A randomized clinical trial. In: Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases. Band21, Nr.3, April 2015, S.120–125, doi:10.1097/RHU.0000000000000235, PMID 25807090.
Christopher M. Burns, Robert L. Wortmann: Latest evidence on gout management: what the clinician needs to know. In: Therapeutic Advances in Chronic Disease. Band3, Nr.6, November 2012, S.271–286, doi:10.1177/2040622312462056, PMID 23342241, PMC 3539261 (freier Volltext).
Erica M. Hill, Karen Sky, Michelle Sit, Angelique Collamer, Jay Higgs: Does starting allopurinol prolong acute treated gout? A randomized clinical trial. In: Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases. Band21, Nr.3, April 2015, S.120–125, doi:10.1097/RHU.0000000000000235, PMID 25807090.
Singer JZ, Wallace SL: The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. In: Arthritis and Rheumatism. 29. Jahrgang, Nr.1, Januar 1986, S.82–87, PMID 3947418.
Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-De la Villa F: Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. In: BMJ (Clinical Research Ed.). 331. Jahrgang, Nr.7517, September 2005, S.623–624, PMID 16166134, PMC 1215560 (freier Volltext).
